{"id":108345,"date":"2024-05-15T16:59:28","date_gmt":"2024-05-15T16:59:28","guid":{"rendered":"https:\/\/www.atlasrleye.com\/?page_id=108345"},"modified":"2025-03-13T10:24:15","modified_gmt":"2025-03-13T10:24:15","slug":"caso-clinico-12","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/es\/retinopatia-diabetica-proliferativa-tipo-1\/caso-clinico-12\/","title":{"rendered":"Caso Cl\u00ednico 12"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=\u00bbRETINOPATIA DIAB\u00c9TICA\u00bb font_container=\u00bbtag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=\u00bbyes\u00bb link=\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Fretinopatia-diabetica%2F|title:Retinopat%C3%ADa%20Diab%C3%A9tica|\u00bb][vc_text_separator title=\u00bb\u00bb i_icon_fontawesome=\u00bbfas fa-eye\u00bb i_color=\u00bbcustom\u00bb i_size=\u00bblg\u00bb color=\u00bbcustom\u00bb border_width=\u00bb8″ css=\u00bb.vc_custom_1637080776101{margin-bottom: -5px !important;}\u00bb add_icon=\u00bbtrue\u00bb accent_color=\u00bb#bababa\u00bb i_custom_color=\u00bb#bababa\u00bb][vc_custom_heading text=\u00bbRetinopat\u00eda Diab\u00e9tica Proliferativa Tipo 1 – Caso Clinico 12″ font_container=\u00bbtag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=\u00bbyes\u00bb css=\u00bb\u00bb link=\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Fes%2Fretinopatia-diabetica-proliferativa-tipo-1%2F|title:RETINOPATIA%20DIAB%C3%89TICA%20PROLIFERATIVA%20TIPO%201|\u00bb]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column]
<\/div>
<\/div>[\/vc_column][\/vc_row][vc_row gap=\u00bb35″ equal_height=\u00bbyes\u00bb][vc_column width=\u00bb1\/2″][vc_row_inner][vc_column_inner width=\u00bb1\/2″][vc_single_image image=\u00bb108360″ img_size=\u00bbmedium\u00bb alignment=\u00bbcenter\u00bb onclick=\u00bblink_image\u00bb css=\u00bb\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text css=\u00bb\u00bb]<\/p>\n

Angiograf\u00eda con fluoresce\u00edna en un paciente de 55 a\u00f1os diagnosticado de diabetes hace m\u00e1s de 20 a\u00f1os, mostrando microaneurismas y \u00e1reas de isquemia. <\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=\u00bb1\/2″][vc_row_inner][vc_column_inner width=\u00bb1\/2″][vc_single_image image=\u00bb108311″ img_size=\u00bbmedium\u00bb alignment=\u00bbcenter\u00bb onclick=\u00bblink_image\u00bb css=\u00bb\u00bb][vc_single_image image=\u00bb108364″ img_size=\u00bbmedium\u00bb alignment=\u00bbcenter\u00bb onclick=\u00bblink_image\u00bb css=\u00bb\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text css=\u00bb\u00bb]<\/p>\n

Ocho meses despu\u00e9s de la cirug\u00eda de catarata (facoemulsificaci\u00f3n y LIO), vitrectom\u00eda y fotocoagulaci\u00f3n con l\u00e1ser (glaucoma neovascular). Tratamiento con inyecciones intraoculares de anti-VEGFs.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Evaluaciones
\n<\/span><\/h3>\n

[\/vc_column_text][vc_tta_accordion active_section=\u00bb99″ no_fill=\u00bbtrue\u00bb collapsible_all=\u00bbtrue\u00bb][vc_tta_section i_icon_fontawesome=\u00bbfar fa-calendar-alt\u00bb add_icon=\u00bbtrue\u00bb title=\u00bb1\u00aa Evaluaci\u00f3n – 14 02 2023″ tab_id=\u00bb1671795919289-748acc60-ba6d\u00bb][vc_row_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Autofluorescencia<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108055,108059″ img_size=\u00bb193*206″ css=\u00bb\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Infrarrojo<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108006,108010″ img_size=\u00bb193*206″ css=\u00bb\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

RNFL \u2013 Mapa de espesor<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108023,108027″ img_size=\u00bb160*206″ css=\u00bb\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb2\/3″][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

OCT del Segmento Anterior<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108014,108019″ img_size=\u00bb300*206″ css=\u00bb\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Fotograf\u00eda del segmento anterior<\/p>\n

\n

Catarata ODI. MAVC: 20\/32 OD; 20\/20 OI.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108031,108035,108039,108043″ img_size=\u00bb300×206″ css=\u00bb.vc_custom_1718621331568{margin-top: -30px !important;}\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108071,107977,107982,107986,107990,107994,107998,108002″ img_size=\u00bb307×110″ css=\u00bb\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Retinograf\u00eda color<\/p>\n

\n

Retinopat\u00eda diab\u00e9tica ODI. HbA1c=8,1%.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108047,108051,108063,108067″ img_size=\u00bb280×206″ css=\u00bb.vc_custom_1718616845969{margin-top: -30px !important;}\u00bb][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=\u00bbfar fa-calendar-alt\u00bb add_icon=\u00bbtrue\u00bb title=\u00bb2\u00aa Evaluaci\u00f3n – 26 06 2023″ tab_id=\u00bb1718621374193-da8b9933-ca52″][vc_row_inner][vc_column_inner][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Angiograf\u00eda con fluoresce\u00edna<\/p>\n

\n

Neovascularizaci\u00f3n del iris. Isquemia marcada de la retina (ODI). Microaneurismas.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108189,108193,108197,108201,108205″ img_size=\u00bb193*206″ css=\u00bb.vc_custom_1718626917098{margin-top: -30px !important;}\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Autofluorescencia<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108181,108185″ img_size=\u00bb183*206″ css=\u00bb\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Infrarrojo<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108135,108139″ img_size=\u00bb183*206″ css=\u00bb\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108217,108131″ img_size=\u00bb183*206″ css=\u00bb\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Fotograf\u00eda del segmento anterior<\/p>\n

\n

MAVC: 8\/10 OD; 10\/10 OI. Neovascularizaci\u00f3n m\u00ednima en el borde del iris (ODI).<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108160,108164,108506,108168″ img_size=\u00bb300×206″ css=\u00bb.vc_custom_1718621676340{margin-top: -30px !important;}\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108144,108148,108152,108156″ img_size=\u00bb307×110″ css=\u00bb\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Retinograf\u00eda color<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108172,108176,108209,108213″ img_size=\u00bb280×206″ css=\u00bb\u00bb][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=\u00bbfar fa-calendar-alt\u00bb add_icon=\u00bbtrue\u00bb title=\u00bb3\u00aa Evaluaci\u00f3n – pos-operatorio – 26 07 2023″ tab_id=\u00bb1671796840330-e71e9361-6fd6″][vc_row_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text]<\/p>\n

\n
\n

Autofluorescencia<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108262,108266″ img_size=\u00bb193×206″ css=\u00bb\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text]<\/p>\n

\n
\n

Infrarrojo<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108241,108245″ img_size=\u00bb193×206″ css=\u00bb\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Fotograf\u00eda del segmento anterior<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108250″ img_size=\u00bb320×206″ css=\u00bb\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108270,108274,108278,108221,108225,108229,108233,108237″ img_size=\u00bb307×110″ css=\u00bb\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Retinograf\u00eda color<\/p>\n

\n

OI, dos semanas despu\u00e9s de la cirug\u00eda de catarata (facoemulsificaci\u00f3n y LIO), vitrectom\u00eda y fotocoagulaci\u00f3n con l\u00e1ser (glaucoma neovascular). Tratamiento con inyecciones intraoculares de aflibercept.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108254,108258″ img_size=\u00bb251×206″ css=\u00bb.vc_custom_1718627101227{margin-top: -30px !important;}\u00bb][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=\u00bbfar fa-calendar-alt\u00bb add_icon=\u00bbtrue\u00bb title=\u00bb4\u00aa Evaluaci\u00f3n – 15 03 2024″ tab_id=\u00bb1671798147691-bfbf7c13-be8d\u00bb][vc_row_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text]<\/p>\n

\n
\n

Autofluorescencia<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108315,108319″ img_size=\u00bb193×206″ css=\u00bb\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text]<\/p>\n

\n
\n

Infrarrojo<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108290,108294″ img_size=\u00bb193×206″ css=\u00bb\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Fotograf\u00eda del segmento anterior<\/p>\n

\n

MAVC: 20\/25 OD; 20\/20 OI. Pseudofaquia ODI.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108298,108303″ img_size=\u00bb307×260″ css=\u00bb.vc_custom_1718627407822{margin-top: -30px !important;}\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108323,108327,108282,108286″ img_size=\u00bb307×110″ css=\u00bb\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=\u00bb\u00bb]<\/p>\n

\n
\n

Retinograf\u00eda color<\/p>\n

\n

Retinopat\u00eda diab\u00e9tica tratada con fotocoagulaci\u00f3n l\u00e1ser e inyecciones intraoculares de anti-VEGFs.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb108307,108311″ img_size=\u00bb251×206″ css=\u00bb.vc_custom_1718627367506{margin-top: -30px !important;}\u00bb][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=\u00bbRETINOPATIA DIAB\u00c9TICA\u00bb font_container=\u00bbtag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=\u00bbyes\u00bb link=\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Fretinopatia-diabetica%2F|title:Retinopat%C3%ADa%20Diab%C3%A9tica|\u00bb][vc_text_separator title=\u00bb\u00bb i_icon_fontawesome=\u00bbfas fa-eye\u00bb i_color=\u00bbcustom\u00bb i_size=\u00bblg\u00bb color=\u00bbcustom\u00bb border_width=\u00bb8″ css=\u00bb.vc_custom_1637080776101{margin-bottom: -5px !important;}\u00bb add_icon=\u00bbtrue\u00bb accent_color=\u00bb#bababa\u00bb i_custom_color=\u00bb#bababa\u00bb][vc_custom_heading text=\u00bbRetinopat\u00eda Diab\u00e9tica Proliferativa Tipo 1 – Caso Clinico 12″ font_container=\u00bbtag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=\u00bbyes\u00bb css=\u00bb\u00bb link=\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Fes%2Fretinopatia-diabetica-proliferativa-tipo-1%2F|title:RETINOPATIA%20DIAB%C3%89TICA%20PROLIFERATIVA%20TIPO%201|\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row gap=\u00bb35″ equal_height=\u00bbyes\u00bb][vc_column width=\u00bb1\/2″][vc_row_inner][vc_column_inner width=\u00bb1\/2″][vc_single_image image=\u00bb108360″ img_size=\u00bbmedium\u00bb alignment=\u00bbcenter\u00bb onclick=\u00bblink_image\u00bb […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":75361,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-108345","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages\/108345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/comments?post=108345"}],"version-history":[{"count":8,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages\/108345\/revisions"}],"predecessor-version":[{"id":114906,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages\/108345\/revisions\/114906"}],"up":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages\/75361"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/media?parent=108345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}